about
Characterization of phagolysosomal simulant fluid for study of beryllium aerosol particle dissolutionDissolution and reactive oxygen species generation of inhaled cemented tungsten carbide particles in artificial human lung fluidsCharacteristics of beryllium oxide and beryllium metal powders for use as reference materialsA theoretical framework for evaluating analytical digestion methods for poorly soluble particulate berylliumSize-selective poorly soluble particulate reference materials for evaluation of quantitative analytical methodsInfluence of artificial gastric juice composition on bioaccessibility of cobalt- and tungsten-containing powdersDifferences in dissolution behavior in a phagolysosomal simulant fluid for single-constituent and multi-constituent materials associated with beryllium sensitization and chronic beryllium diseaseCharacterization of physicochemical properties of beryllium aerosols associated with prevalence of chronic beryllium diseaseSurface area of respirable beryllium metal, oxide, and cooper alloy aerosols and implications for assessment of exposure risk of chronic beryllium diseaseDifferences in estimates of size distribution of beryllium powder materials using phase contrast microscopy, scanning electron microscopy, and liquid suspension counter techniquesValidation of analytical methods and instrumentation for beryllium measurement: review and summary of available guides, procedures, and protocolsThe nanoparticle information library (NIL): A prototype for linking and sharing emerging dataPerformance evaluation of the sampling head and annular kinetic impactor in the Savannah River Site alpha continuous air monitorThe Nanomaterial Data Curation Initiative: a collaborative approach to assessing, evaluating, and advancing the state of the fieldExposures and cross-shift lung function declines in wildland firefightersInformatics and standards for nanomedicine technologyRegulatory T cells modulate granulomatous inflammation in an HLA-DP2 transgenic murine model of beryllium-induced diseaseCharacterization of exposures to airborne nanoscale particles during friction stir welding of aluminumEfficacy of a technique for exposing the mouse lung to particles aspirated from the pharynxBioavailability of beryllium oxide particles: an in vitro study in the murine J774A.1 macrophage cell line modelExposure pathway assessment at a copper-beryllium alloy facilityOpportunities and challenges of nanotechnology in the green economyIdentification and characterization of potential sources of worker exposure to carbon nanofibers during polymer composite laboratory operations'Toxic' and 'Nontoxic': confirming critical terminology concepts and context for clear communicationRaw single-wall carbon nanotubes induce oxidative stress and activate MAPKs, AP-1, NF-kappa B, and Akt in normal and malignant human mesothelial cellsRadioactive aerosolsApplication of an informatics-based decision-making framework and process to the assessment of radiation safety in nanotechnologyCommentary on the contributions and future role of occupational exposure science in a vision and strategy for the discipline of exposure scienceCertification of beryllium mass fraction in SRM 1877 beryllium oxide powder using high-performance inductively coupled plasma optical emission spectrometry with exact matchingOccupational safety and health criteria for responsible development of nanotechnologyOccupational risk management of engineered nanoparticlesOpportunities for development of reference materials for berylliumAerosol dosimetry research needsNanoinformatics workshop report: current resources, community needs and the proposal of a collaborative framework for data sharing and information integrationParticle size-dependent radical generation from wildland fire smokePreparation, certification and interlaboratory analysis of workplace air filters spiked with high-fired beryllium oxide2015 Health Physics Society Honor Roll - James J. "Jim" ThompsonToward the responsible development and commercialization of sensor nanotechnologiesSpecific blood absorption parameters for 239PuO2 and 238PuO2 nanoparticles and impacts on bioassay interpretationSharpening the focus on occupational safety and health in nanotechnology
P50
Q23909395-C55C303F-A4D8-4EA5-A3E5-5378FBE6E11CQ23909397-72430FD1-90D6-4BC8-BB18-4594DB2D5D65Q23909550-25A4F6DF-89D1-4963-982C-81506A09B3BBQ23909676-FE74547E-0B13-4A9C-A25F-56757F6DBA9CQ23909677-69B4AC70-F8DB-404F-8BE7-15DA1509E54CQ23909679-C6EC6232-EB7F-45B1-A2CE-397527A66EDDQ23909680-A39C711C-2D5A-40EB-BA71-6DD6D015687EQ23909683-6723D5EE-26FE-4983-8C99-605FF05D9D0EQ23909688-CD3B066E-2BD7-4B66-9598-CA183B18CEF6Q23909693-4EE80C91-3D4D-49ED-A8BC-7D621A5EBD2AQ23909826-F3048483-F8FF-4689-B8FE-BFC1E0C7B491Q23910115-18CA7CC4-F6D0-4B57-907E-16ECCDC2C13CQ23910343-9F1E0E74-A95A-448C-A1AC-0B3BD19A0D86Q23911115-20edac70-4383-b91a-9c0a-1a4015a6bd9bQ23912029-ea59968a-4723-f47d-1d83-b9766ac683daQ23912034-6e24efe0-4bb7-8257-51e3-873e6e341a05Q23912235-6BA6F4D8-A9DD-4C55-AD95-20511227073EQ23912788-C205CDA4-2A87-4D85-9F24-1EFFD6B5E617Q23912992-5195bba5-4ed3-2e13-21a4-1a61d54deaccQ23913233-4293A008-ABD6-4D84-9937-9E327DD2CD33Q23913234-55D73FD2-27D4-4D90-87AB-B46ADC9CF8FDQ23913786-4F2C2657-731E-40FE-878C-99C69DA8E2F1Q23916774-E9B0F455-D9AC-45AE-8F01-44961BB61782Q23917288-36956EF9-EF6D-47DD-A51A-2D65137C749EQ23917646-74dc74cb-4b8d-e1e3-f2e9-aa5b9138b3d4Q23917710-26CC949E-E18E-4D99-B0C4-52EA199AB31DQ23917711-39191C42-9E56-492F-9CFD-994411C721CBQ23917711-42131267-3117-405A-8EAD-D18A719E0159Q23917863-B926ABBC-8D98-490C-808E-9121C06FE169Q23918377-8AF55944-DEA6-4AC2-9877-3ABA64578093Q23919010-B6B24D42-32B9-4F07-A82F-6CF489925171Q23919351-653e1f9f-4376-1f50-e769-d18f350b3ab7Q23920207-E78EDDE3-4BFE-4582-9217-0CCBC545652DQ23920273-337A8F56-E64D-4F76-ACD2-F0610BF102EFQ23921579-36d1a8cd-4994-28f3-09d8-3aa47f66b9ecQ23921765-ec7664b3-410a-5350-c612-4d19a2634805Q23922611-ef0861cb-43a7-45dc-4fa6-8241e27721a3Q23923525-28C354E7-BB00-4865-8428-F193016F668EQ24170377-442F66AF-DC99-4B21-A1B2-B3BE18ECD183Q24170425-a79ecc01-43bc-eaff-3589-ea05d2b16c32
P50
description
American health and safety scientist
@en
Amerikaans onderzoeker
@nl
name
Mark D. Hoover
@ast
Mark D. Hoover
@en
Mark D. Hoover
@es
Mark D. Hoover
@ga
Mark D. Hoover
@nl
Mark D. Hoover
@sl
type
label
Mark D. Hoover
@ast
Mark D. Hoover
@en
Mark D. Hoover
@es
Mark D. Hoover
@ga
Mark D. Hoover
@nl
Mark D. Hoover
@sl
altLabel
M Hoover
@en
MD Hoover
@en
Mark Douglas Hoover
@en
Mark Hoover
@en
prefLabel
Mark D. Hoover
@ast
Mark D. Hoover
@en
Mark D. Hoover
@es
Mark D. Hoover
@ga
Mark D. Hoover
@nl
Mark D. Hoover
@sl
P106
P108
P69
P214
P1053
I-4201-2012
P108
P1153
7005502458
P19
P1960
diq6dFoAAAAJ
P21
P214
P31
P3829
P4012
P496
0000-0002-8726-8127
P569
1948-08-09T00:00:00Z
P734
P7859
lccn-n84043569